Sexual precocity in a 2-year-old boy caused by indirect exposure to testosterone cream

Endocrine Practice

Volumn 14, Issue 8, 2008, Pages 1027-1030

  Stephen, Matthew D ^a   Jehaimi, Cayce T ^a   Brosnan, Patrick G ^a   Yafi, Michael ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ARTICLE; BONE AGE; CASE REPORT; CHILD; CLINICAL ASSESSMENT; DRUG EXPOSURE; HUMAN; LABORATORY TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRECOCIOUS PUBERTY; PRESCHOOL CHILD; RADIODIAGNOSIS; TESTICULAR ENLARGEMENT; CHEMICALLY INDUCED DISORDER; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; CHILD, PRESCHOOL; HUMANS; MALE; PUBERTY, PRECOCIOUS; TESTOSTERONE;

EID: 65849146730     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.8.1027     Document Type: Article

References (17)

1. Tostain JL, Blanc F. Testosterone deficiency: a common, unrecognized syndrome. Nat Clin Prac Urol. 2008;5:388-396.
2. Yu YM, Punyasavatsu N, Elder D, D'Ercole AJ. Sexual development in a two-year-old boy induced by topical exposure to testosterone. Pediatrics. 1999;104:e23.
3. Franklin SL, Geffner ME. Precocious puberty secondary to topical testosterone exposure. J Pediatr Endocrinol Metab. 2003;16:107-110.
4. Svoren BM, Wolfsdorf JI. Sexual development in a 21 month-old boy caused by testosterone contamination of a topical hydrocortisone cream. J Pediatr Endocrinol Metab. 2005;18:507-510.
5. Brachet C, Vermeulen J, Heinrichs C. Children's virilization and the use of a testosterone gel by their fathers. Eur J Pediatr. 2005;164:646-647.
6. Bhowmick SK, Ricke T, Rettig KR. Sexual precocity in a 16-month-old boy induced by indirect topical exposure to testosterone. Clin Pediatr (Phila). 2007;46:540-543.
7. Kunz GJ, Klein KO, Clemens RD, Gottschalk ME, Jone KL. Virilization of young children after topical androgen use by their parents. Pediatrics. 2004;114:282-284.
8. Rolf C, Knie U, Lemmnitz G, Nieschlag E. Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation. Clin Endocrinol (Oxf). 2002;56:637-641.
9. Carel JC, Léger J. Clinical practice. Precocious puberty. N Engl J Med. 2008;358:2366-2377.
10. Araujo AB, Esche GR, Kupelian V, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92:4241-4247.
11. Srinivas-Shankar U, Wu FC. Drug insight: testosterone preparations. Nat Clin Pract Urol. 2006;3:653-665.
12. Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man [erratum in N Engl J Med. 1995;332:131].
13. N Engl J Med. 1994;331:1056-1061.
14. Flor-Cisneros A, Leschek EW, Merke DP, et al. In boys with abnormal developmental tempo, maturation of the skeleton and the hypothalamic-pituitary-gonadal axis remains synchronous. J Clin Endocrinol Metab. 2004;89:236-241.
15. Levy JB, Seay TM, Tindall DJ, Husmann DA. The effects of androgen administration on phallic androgen receptor expression. J Urol. 1996;156:775-779.
16. Sutherland RS, Kogan BA, Baskin LS, et al. The effect of prepubertal androgen exposure on adult penile length. J Urol.1996;156: 783-787.
17. Bin-Abbas B, Conte FA, Grumbach MM, Kaplan SL. Congenital hypogonadotropic hypogonadism and micropenis: effect of testosterone treatment on adult penile size why sex reversal is not indicated. J Pediatr. 1999;134:579-583.